Compare ULCC & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ULCC | RAPP |
|---|---|---|
| Founded | 1994 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2021 | 2024 |
| Metric | ULCC | RAPP |
|---|---|---|
| Price | $4.90 | $30.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | $5.56 | ★ $47.80 |
| AVG Volume (30 Days) | ★ 5.1M | 381.6K |
| Earning Date | 02-06-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,729,000,000.00 | N/A |
| Revenue This Year | $0.37 | N/A |
| Revenue Next Year | $14.59 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.77 | N/A |
| 52 Week Low | $2.89 | $6.43 |
| 52 Week High | $10.26 | $42.27 |
| Indicator | ULCC | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 50.71 | 59.91 |
| Support Level | $4.89 | $28.03 |
| Resistance Level | $5.57 | $31.52 |
| Average True Range (ATR) | 0.36 | 1.97 |
| MACD | -0.06 | 0.06 |
| Stochastic Oscillator | 25.00 | 85.33 |
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.